A 6% dividend increase has been announced by Pfizer, Inc. (PFE). Thanks to two dividend increases and quarterly dividend reinvestment, my next payment will be 20% higher than the first one 1 1/2 years earlier.
During the time that I have owned PFE, my shares have also increased in value. I will soon have 16 shares of the stock rather than the 15 that I purchased.
There is some question of whether or not Pfizer will stay in this portfolio indefinitely, since its dividend yield and typical dividend increases together do not grow fast enough to keep pace with my expectation of $560 per month in dividends by December 2035. But in the short term, it is definitely staying put in the nP portfolio.
No comments:
Post a Comment